The mechanism of action of mRNA vaccines goes far beyond harnessing host cellular machinery to produce antigenic proteins to spur immunity, write Nicolas Hulscher, M.P.H., Peter A. McCullough, M.D., M ...

Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...

Researchers delivered mRNA to testicular cells in infertile mice to correct a genetic defect blocking sperm production. The temporary treatment restored spermatogenesis and enabled fertilization, ...

How can cells be programmed to respond to complex signals and make targeted decisions, similar to a logical circuit in a ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine, dashing investors’ confidence in the firm’s ...

Researchers have found that targeted delivery of messenger RNA (mRNA) can restore sperm production and fertility in ...

Company leaders to engage the global research community on circular RNA, AI-driven therapeutics, and next-generation ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

U.S. mRNA Therapeutics Market is estimated at USD 6.85 billion in 2025 and is expected to reach USD 33.04 billion by 2035 owing to the extensive biotechnology infrastructure in the countryAustin, ...